176 related articles for article (PubMed ID: 22011808)
1. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.
Lima LM; Carvalho Md; Fonseca Neto CP; Garcia JC; Sousa MO
Arq Bras Cardiol; 2011 Dec; 97(6):462-389. PubMed ID: 22011808
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
[TBL] [Abstract][Full Text] [Related]
3. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes.
Iwai N; Shimoike H; Nakamura Y; Tamaki S; Kinoshita M
Atherosclerosis; 1998 Jan; 136(1):109-14. PubMed ID: 9544737
[TBL] [Abstract][Full Text] [Related]
4. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease.
Margaglione M; Cappucci G; Colaizzo D; Giuliani N; Vecchione G; Grandone E; Pennelli O; Di Minno G
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):152-6. PubMed ID: 9484978
[TBL] [Abstract][Full Text] [Related]
5. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
Zhang AY; Ji XW; Guan LX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):233-5. PubMed ID: 18393255
[TBL] [Abstract][Full Text] [Related]
6. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
[TBL] [Abstract][Full Text] [Related]
8. Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.
Zietz B; Buechler C; Drobnik W; Herfarth H; Schölmerich J; Schäffler A
Endocr Res; 2004 Aug; 30(3):443-53. PubMed ID: 15554360
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
Li YY
PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
[TBL] [Abstract][Full Text] [Related]
10. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
11. 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.
Burzotta F; Iacoviello L; Di Castelnuovo A; Zamparelli R; D'Orazio A; Amore C; Schiavello R; Donati MB; Maseri A; Possati G; Andreotti F
J Thromb Thrombolysis; 2003 Dec; 16(3):149-54. PubMed ID: 15087600
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.
Anderson JL; Muhlestein JB; Habashi J; Carlquist JF; Bair TL; Elmer SP; Davis BP
J Am Coll Cardiol; 1999 Nov; 34(6):1778-83. PubMed ID: 10577569
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion.
von Känel R; Maly FE; Frey K; Fischer JE
Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709
[TBL] [Abstract][Full Text] [Related]
16. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
Gardemann A; Lohre J; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.
Nagi DK; McCormack LJ; Mohamed-Ali V; Yudkin JS; Knowler WC; Grant PJ
Diabetes Care; 1997 Aug; 20(8):1304-9. PubMed ID: 9250459
[TBL] [Abstract][Full Text] [Related]
19. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
Xu F; Liu H; Sun Y
Ren Fail; 2016; 38(1):157-62. PubMed ID: 26616527
[TBL] [Abstract][Full Text] [Related]
20. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]